Allspring Global Investments Holdings LLC Reduces Stock Position in Humana Inc. $HUM

Allspring Global Investments Holdings LLC cut its stake in Humana Inc. (NYSE:HUM) by 9.0% in the second quarter, Holdings Channel.com reports. The firm owned 689,604 shares of the insurance provider’s stock after selling 68,398 shares during the quarter. Allspring Global Investments Holdings LLC’s holdings in Humana were worth $174,180,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in HUM. Vanguard Group Inc. grew its position in shares of Humana by 8.9% in the first quarter. Vanguard Group Inc. now owns 13,972,872 shares of the insurance provider’s stock valued at $3,697,222,000 after purchasing an additional 1,143,662 shares in the last quarter. AQR Capital Management LLC grew its position in shares of Humana by 3,257.5% in the first quarter. AQR Capital Management LLC now owns 1,162,600 shares of the insurance provider’s stock valued at $307,624,000 after purchasing an additional 1,127,973 shares in the last quarter. Nuveen LLC purchased a new position in Humana in the first quarter worth approximately $171,220,000. Dodge & Cox grew its position in Humana by 5.5% in the first quarter. Dodge & Cox now owns 10,755,215 shares of the insurance provider’s stock worth $2,845,830,000 after acquiring an additional 557,175 shares during the period. Finally, Pzena Investment Management LLC grew its position in Humana by 6.1% in the first quarter. Pzena Investment Management LLC now owns 3,828,923 shares of the insurance provider’s stock worth $1,013,133,000 after acquiring an additional 219,541 shares during the period. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

HUM has been the subject of several analyst reports. Guggenheim reiterated a “buy” rating on shares of Humana in a research report on Friday, October 3rd. Piper Sandler lowered their price objective on Humana from $288.00 to $272.00 and set a “neutral” rating for the company in a research report on Thursday, July 31st. Mizuho increased their price objective on Humana from $300.00 to $345.00 and gave the stock an “outperform” rating in a research report on Thursday. Royal Bank Of Canada increased their price objective on Humana from $283.00 to $322.00 and gave the stock an “outperform” rating in a research report on Thursday, August 21st. Finally, Morgan Stanley lowered their price objective on Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $298.83.

Humana Stock Down 3.6%

Shares of NYSE HUM opened at $280.24 on Monday. The stock has a market cap of $33.71 billion, a P/E ratio of 21.51, a PEG ratio of 1.64 and a beta of 0.42. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. Humana Inc. has a 12-month low of $206.87 and a 12-month high of $315.35. The business’s fifty day simple moving average is $279.45 and its 200-day simple moving average is $258.04.

Humana (NYSE:HUM) last posted its quarterly earnings results on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. During the same quarter in the prior year, the business earned $6.96 earnings per share. The firm’s quarterly revenue was up 9.6% on a year-over-year basis. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, equities analysts predict that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Friday, September 26th. This represents a $3.54 annualized dividend and a dividend yield of 1.3%. Humana’s dividend payout ratio (DPR) is presently 27.17%.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.